Overview
GH market data
Price History
GH price chart · 1M
- O
- 176.54
- H
- 179.77
- L
- 175.64
- C
- 177.34
- Vol
- 98,618.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $176.54
- Previous Close
- $176.40
- Day High
- $179.77
- Day Low
- $175.64
- 52 Week High
- $183.39
- 52 Week Low
- $122.98
- 7 Day Return
- -1.13%
- 30 Day Return
- +3.79%
- 90 Day Return
- +15.37%
- 1 Year Return
- +37.30%
- Daily Notional Volume
- $17.5M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$3.32 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.73 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -38.3% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $55.38 – $183.51 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $23.6B · P/B 20.69 · P/S 19.98.
Company News
10 captured
AstraZeneca Secures FDA Nod for New Breast Cancer Therapy EtcamahZacks Investment Research ·